Lantern Pharma Inc Stock Quote | Stock Price for LTRN | FinancialContent Business Page
FinancialContent fully hosted finance channel
Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinancialContent fully hosted finance channel
DALLAS, TX / ACCESSWIRE / August 19, 2022 / RedChip Companies will air a new interview on Lantern Pharma Inc. (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial
Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 89,700 shares, a drop of 40.4% from the May 15th total of 150,500 shares. Currently, 1.2% of the shares of the company are short […]
The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020...
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...